A. Hameed et al., 3,4-DICHLOROISOCOUMARIN SERINE-PROTEASE INHIBITOR INDUCES DNA FRAGMENTATION AND APOPTOSIS IN SUSCEPTIBLE TARGET-CELLS, Proceedings of the Society for Experimental Biology and Medicine, 219(2), 1998, pp. 132-137
3,4-Dichloroisocoumarin (DCI) inhibition of serine proteases generates
reactive intermediates that have been theorized to affect apoptosis,
To examine this possibility various target cells were treated with dif
ferent concentrations of DCI and assessed for intracellular nuclear DN
A fragmentation and apoptosis, DCI treatment caused oligonucleosomal D
NA fragmentation in cell lines expressing high levels of protease acti
vity (LAK cells, NK-92, CTLL-2, L929, 3T3). This DNA breakdown charact
eristic of apoptosis occurred in a dose-dependent fashion within 4-6 h
r of treatment and was confirmed by electron microscopy. In cell lines
expressing low levels of protease activity (unstimulated human periph
eral blood mononuclear (PBMN) cells, YAC-1 cells), DCI effectively inh
ibited protease activity without inducing oligonucleosomal DNA fragmen
tation. ZN(2+) ions significantly inhibited DCI-induced DNA degradatio
n. The mixture of DCI and BLT esterase active NK cell lysate triggered
DNA fragmentation in isolated YAC-1 nuclei. Degree of DNA fragmentati
on in YAC-1 nuclei was proportional to the level of BLT esterase activ
ity, Cell lysate protease activity, initially inhibited by DCI acylati
on, was restored by hydroxylamine deacylation, thus preventing DCI-med
iated DNA fragmentation. Our results suggest that DCI treatment of cel
ls expressing high levels of protease activity generates toxic levels
of acyl-enzyme intermediates. These intermediates may trigger nuclear
DNA breakdown and apoptosis by activating endogenous endonucleases, Th
is effect may compromise the analysis of apoptosis in experimental sys
tems using high concentrations of DCI for extended periods.